Researchers have found that magnesium supplementation reduces blood pressure in adults with hypertension and those with hypomagnesemia.

Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that Revuforj ® (revumenib) was named Best New Drug at the ...

According to a new study published in JAMA Internal Medicine routine magnesium supplementation does not result in lower rates of tachyarrhythmias, hypotension, or death in critically ill ...

Magnesium is a mineral that plays a vital role in maintaining the health of muscles, nerves, bones and blood sugar levels in the body. According to the National Institutes of Health, the adult body ...

This study retrospectively analyzed ten pediatric patients with HOX-driven AML who received revumenib maintenance after HSCT at a single-center. The median age was 10 years (range: 1-18). 80% (8/10) ...

KOMZIFTI (ziftomenib), the first and only once-daily oral menin inhibitor for adult patients with R/R AML with a susceptible NPM1 mutation who have no satisfactory alternative treatment options, has ...

Medically reviewed by Elizabeth Barnes, RDN Key Takeaways Most healthy people get enough magnesium from food, but certain ...

ENHERTU Plus Pertuzumab Approved in the U.S. for First-Line Treatment of Patients with HER2 Positive Metastatic Breast Cancer ...